Crossmark

Safety, effectiveness, and economic evaluation of an herbal medicine, Ukgansangajinpibanha granule, in children with autism spectrum disorder: a study protocol for a prospective, multicenter, randomized, double-blinded, placebo-controlled, parallel-group clinical trial

Crossref DOI link: https://doi.org/10.1186/s13063-019-3537-7

Published Online: 2019-07-15

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, Sun Haeng

Shin, Seungwon

Kim, Tae-hun

Kim, Sang Min

Do, Tae Yoon

Park, Sulgi

Lee, Boram

Shin, Hye Jin

Lee, Jihong

Lee, Jin Yong

Chang, Gyu Tae https://orcid.org/0000-0002-2465-3298
Funding

Funding for this research was provided by:

Ministry of Health and Welfare (HB16C0075)
License Information

Text and Data Mining valid from 2019-07-15

Version of Record valid from 2019-07-15
More Information

Article History

Received: 14 August 2018

Accepted: 22 June 2019

First Online: 15 July 2019

Ethics approval and consent to participate

: The trial protocol has been approved by the Ministry of Food and Drug Safety (#31635) and the institutional review board at Kyung Hee University Korean Medicine Hospital at Gangdong (KHNMCOH 2017–08-008) and Kyung Hee University Korean Medicine Hospital (KOMCIRB 2017–10-041).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below